TCL Archive Two Groups Take Different Approaches To Managing Toxicity Of Saltz Regimen. June 22, 2001
TCL Archive In Brief: Krakoff To Head New M.D. Anderson Division, Two Other Appointments Made In Reorganization There July 22, 1983
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
